Meanwhile, TUDCA has the ability to promote the signaling pathway known as PI3K/Akt in AD (Solá et al., 2003), leading to the inhibition of p53 expression and subsequent regulation of Tau phosphorylation. The gene discussed is MAPT; the disease is Alzheimer disease.